Hi-Tech Pharmaceuticals Announced Phase 2 Launch of PRO IGF-1® the First Actual IGF-1 Peptide in a Dietary Supplement
PR Newswire
NORCROSS, Ga., Sept. 17, 2026
NORCROSS, Ga., Sept. 17, 2026 /PRNewswire/ -- Hi-Tech Pharmaceuticals, Inc., today announced the Phase 2 nationwide launch of its PRO IGF-1® Peptide dietary supplement. Hi-Tech has been able to launch a natural dietary supplement using the extraction of IGF-1 production of Insulin-like growth factor type 1 Peptide (IGF-1) from whey protein. Hi-Tech used a molecular biological technique to extract 175 ug/100g, which is a substantial amount of IGF-1. Hi-Tech's announcement of the Phase 2 nationwide launch of PRO IGF-1® follows the company's success in Phase 1 PRO IGF-1®'s distribution along with producing many other proprietary and patented compounds such as: 1-DHEA, 4-DHEA, 19-Nor DHEA, Senegalia Berlandieri, and many other cutting edge sports nutrition products.
Considering the many clinical and research applications of IGF-1, a ready supply of IGF-1 would be of great value to the medical and biotechnology fields. Since isolation from natural sources previously had been technically difficult, expensive, and time consuming, recent efforts by Hi-Tech have centered on the development of efficient extraction methods from whey peptides for the production of IGF-1 Peptides.
The so-called growth factors in whey peptides, growth hormone (GH) and the insulin-like growth factors (IGFs), are not mutually exclusive in terms of their effects. It is well documented that the influence of growth hormone on the proliferation of new cells in the body occurs primarily through what is known as the GH/IGF axis wherein the presence of GH triggers and enhances the many effects of the IGFs. IGF-1, or insulin like growth factor-1, has also found favor among athletes for the same reasons that its better-known relative human growth hormone has: it is believed to make an athlete bigger, faster and stronger. It may boost muscle, reduce fat and improve endurance.
IGF-1 is made in response to growth hormone and is needed for growth hormone to have its effects on muscles and other tissues. Growth hormone, synthesized in the pituitary gland, travels to the liver, which then responds by producing IGF-1. IGF-1 consists of 70 amino acids in a single chain with three intermolecular disulfide bridges. Insulin-like growth factor type 1—commonly known as IGF-1—is a hormone produced naturally in the liver and involved in the human body's growth and development. IGF-1 is at its highest level in the body during childhood and adolescence.
Why IGF-1 and not GH? Growth hormone actually is a precursor to IGF-1. Growth hormone does not directly cause muscle growth, but indirectly causes muscle growth by signaling the release of IGF-1. Unlike growth hormone studies suggest that IGF-1 Peptides are stable and can be absorbed in the GI tract by neonates. Hi-Tech Pharmaceuticals takes a great invention (IGF-1 peptide derived from whey) and makes it a superior product (Pro IGF-1®). Our proprietary in-house Liposomal Delivery (LD) system (Cyclosome®) is an applied coating which allows IGF-1 to readily dissolve in liquids and ensures the IGF-1 will bypass digestion; will be transported through the bowel wall; will circulate throughout the body; will reach the organs and cells; and remain bioavailable at the cellular level. Liposomal Delivery makes IGF-1 (and other hormones and nutrients) up to 1,500 % more bioavailable. Without Liposomal Delivery, IGF-1 loses most of its effectiveness. The Cyclosome® Delivery Difference means that IGF-1 products from Hi-Tech do what they say.
About Hi-Tech Pharmaceuticals
Hi-Tech Pharmaceuticals (https://www.hitechpharma.com/index.htm) is a leading Sports Nutrition manufacturer. Since 1979, Hi-Tech Pharmaceuticals, Inc. and its sister company, Hi-Tech Nutraceuticals, LLC. have been providing quality custom manufacturing services to the pharmaceutical, dietary supplement and beverage industries. Hi-Tech Pharmaceuticals is a cGMP certified company that operates out of Four (4) US Production facilities and (3) Warehouses, totally over 500,000 sq. ft. The two Georgia based production facilities are both located outside Atlanta in the Norcross and Suwanee Advanced Technology areas. Hi-Tech also has Two (2) facilities located outside State College, Pennsylvania. Hi-Tech holds a Drug Manufacturing License issued by the State of Pennsylvania Food and Drug Branch and is registered as a Food and Drug Establishment with the FDA in Pennsylvania.
Hi-Tech Pharmaceuticals is an enormously successful company that creates, manufactures and sells high-quality products sold by the large, major retailers across the United States.
Media Contact:
Michelle Harris
770-797-9959
422905@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-announced-phase-2-launch-of-pro-igf-1-the-first-actual-igf-1-peptide-in-a-dietary-supplement-302881877.html
SOURCE Hi-Tech Pharmaceuticals, Inc.


